About Ophthalmology


Energy to Eye Care: Since the introduction of the first laser photocoagulator to ophthalmology in 1970, Lumenis Vision has focused on providing ophthalmologists with innovative laser therapies to preserve and improve the sight of patients worldwide.

Lumenis Vision is renowned for technological breakthroughs in ophthalmic lasers and a long list of industry gold standards. Our company pioneered the first argon laser photocoagulator for ophthalmology; the first approved marketer of Nd:YAG photodisruptor lasers; developed and introduced the breakthrough technology of multicolor photocoagulation along with the world's first Laser Indirect Ophthalmoscope (LIO); developed and brought to market the revolutionary SLT technology for managing POAG, and more.

Today, Lumenis Vision offers you the confidence of doing business with a company that is truly committed to ophthalmology and to meeting your needs.

  • About Lumenis
  • About Lumenis

Product Overview


M22 OPTTM

Eyelid inflammation affects millions of Indians every year. Over 85% of eyelid inflammation patients also suffer from inflammatory ocular conditions.

Lumenis invites you to think outside the eye and offer your patients a solution to their dry eye related problems with M22 OPTTM. M22TM combines Intense Pulsed Light (IPL) with unique Optimal Pulse Technology (OPTTM).

Event Gallery


Event & Conferences at a glance

Lumenis Vision feels proud to bring to you highly informative education and trainings platforms through participation in various scientific sessions & workshops where you can learn more about our ground-breaking technologies and the opportunities they offer for your practice.

Phaco Festival 2018, Bengaluru

Lumenis participated in the event with major focus on enlightening audiences about our breakthrough & revolutionary technology for treatment of Dry Eyes. The scientific session on M22 OPT for Dry Eyes by Dr Chandanlatha from Nethradhama, Bengaluru was a big success with full house attendances. Our booth witnessed excellent interactions between doctors and Sales team.

M22 OPT Training Event

Lumenis India in collaboration with Centre for Sight organized an exclusive M22 OPT training through webinar with Dr Rolando Toyos, medical Director and Founder - Toyos Clinic who pioneered use of M22 OPT treatment for Dry Eyes. The event was held at Metropolitan Hotel, New Delhi. More than 40 doctors from Centre for Sight participated in the event and 35 doctors from other parts of India also participated through webinar.

  • Pics of Events
  • Pics of Events
  • Pics of Events
  • Pics of Events
  • Pics of Events
  • Pics of Events
  • Pics of Events
  • Pics of Events

Media


Testimonials


What Our Partners Have to Say?

It's time to know about you! Feel free to fill out the contact form